+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
REGN4461 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

REGN4461 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 164 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
COSENTYX Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

COSENTYX Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
ENSPRYNG Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENSPRYNG Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Psoriatic Arthritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
Food Allergy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Food Allergy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 144 Pages
  • Global
From
Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • February 2022
  • 210 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 105 Pages
  • Global
From
Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Market Insights, Epidemiology, and Market Forecast - 2030 - Product Thumbnail Image

Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Market Insights, Epidemiology, and Market Forecast - 2030

  • Report
  • January 2022
  • 92 Pages
  • Global
From
Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Adult-onset Still's Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Adult-onset Still's Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sjogren's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sjogren's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more